Vanguard Fiduciary Trust
CTXR icon

Vanguard Fiduciary Trust’s Citius Pharmaceuticals CTXR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Hold
77,755
– – ﹤0.01% 3877
2026
Q1 		$70K Buy
+77,755
New +$62.8K ﹤0.01% 3772

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
BW
BostonPremier Wealth Hanover, Massachusetts $235M AUM 31.01% 1-Year Est. Return

Vanguard Fiduciary Trust's CTXR Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Citius Pharmaceuticals (CTXR) position steady in Q2 2026 at 77,755 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #3877.

Vanguard Fiduciary Trust first reported a position in CTXR in Q1 2026 and has held it in 2 quarters since. The position peaked at $70K in Q1 2026. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Vanguard Fiduciary Trust held 77,755 shares of Citius Pharmaceuticals worth $47K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Citius Pharmaceuticals share count unchanged in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3877 holding.
  • Vanguard Fiduciary Trust first reported a position in Citius Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Citius Pharmaceuticals position peaked at $70K in Q1 2026.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.